Fang JW - Search Results

1

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.

Glue P, Fang JW, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, Jacobs S. Glue P, et al. Among authors: fang jw. Clin Pharmacol Ther. 2000 Nov;68(5):556-67. doi: 10.1067/mcp.2000.110973. Clin Pharmacol Ther. 2000. PMID: 11103758 Clinical Trial.

2

Quantification of serum hepatitis C virus RNA.

Fang JW, Albrecht JK, Jacobs S, Lau JY. Fang JW, et al. Hepatology. 1999 Mar;29(3):997-8. doi: 10.1002/hep.510290316. Hepatology. 1999. PMID: 10189235 No abstract available.

3

Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.

Ferrari E, Wright-Minogue J, Fang JW, Baroudy BM, Lau JY, Hong Z. Ferrari E, et al. Among authors: fang jw. J Virol. 1999 Feb;73(2):1649-54. doi: 10.1128/JVI.73.2.1649-1654.1999. J Virol. 1999. PMID: 9882374 Free PMC article.

4

The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.

Gordon SC, Fang JW, Silverman AL, McHutchison JG, Albrecht JK. Gordon SC, et al. Among authors: fang jw. Hepatology. 2000 Aug;32(2):400-4. doi: 10.1053/jhep.2000.9321. Hepatology. 2000. PMID: 10915749

5

Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C.

González-Peralta RP, Fang JW, Davis GL, Gish RG, Kohara M, Mondelli MU, Urdea MS, Mizokami M, Lau JY. González-Peralta RP, et al. Among authors: fang jw. Dig Dis Sci. 1995 Dec;40(12):2595-601. doi: 10.1007/BF02220447. Dig Dis Sci. 1995. PMID: 8536518

6

Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients.

Gish RG, Lau JY, Brooks L, Fang JW, Steady SL, Imperial JC, Garcia-Kennedy R, Esquivel CO, Keeffe EB. Gish RG, et al. Among authors: fang jw. Hepatology. 1996 Jan;23(1):1-7. doi: 10.1002/hep.510230101. Hepatology. 1996. PMID: 8550028

7

Hepatic expression of interferon-alpha in chronic hepatitis B virus infection.

Fang JW, Wu PC, Lai CL, Lo CK, Meager A, Lau JY. Fang JW, et al. Dig Dis Sci. 1994 Sep;39(9):2014-21. doi: 10.1007/BF02088140. Dig Dis Sci. 1994. PMID: 8082512

8

HIV-induced HBV breakthrough during interferon-alpha therapy.

Fang JW, Lau JY, Davis GL. Fang JW, et al. Am J Gastroenterol. 1993 Aug;88(8):1293-4. Am J Gastroenterol. 1993. PMID: 8338110 No abstract available.

9

Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients.

Slimane SB, Albrecht JK, Fang JW, Goodman Z, Mizokami M, Qian K, Lau JY. Slimane SB, et al. Among authors: fang jw. J Viral Hepat. 2000 Jan;7(1):51-5. doi: 10.1046/j.1365-2893.2000.00188.x. J Viral Hepat. 2000. PMID: 10718943

10

Detection of hepatitis E virus genome and gene products in two patients with fulminant hepatitis E.

Lau JY, Sallie R, Fang JW, Yarbough PO, Reyes GR, Portmann BC, Mieli-Vergani G, Williams R. Lau JY, et al. Among authors: fang jw. J Hepatol. 1995 Jun;22(6):605-10. doi: 10.1016/0168-8278(95)80215-0. J Hepatol. 1995. PMID: 7560853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters